Mouridsen
Brian Mouridsen, Fredensborg DK
Patent application number | Description | Published |
---|---|---|
20140039409 | Device for Injecting Adjustable Doses of Liquid Drug - The present invention relates to an injection device for administering doses of liquid drug. The injection device comprises a user operable dose adjustment structure configured to adjust, in a prepared state of the device, a dose of liquid drug of a first size to set a dose of a second size. The present injection device is particularly suitable for self-injection of liquid drugs such as insulin for treating diabetes by the user or patient. | 02-06-2014 |
20140200519 | MEDICAL DEVICE HAVING USER FRIENDLY CONTROL INPUT - The present invention relates to a medical delivery comprising a) a housing ( | 07-17-2014 |
20140257195 | Medical Injection System Comprising a Medical Injection Device and a Dose Limiter Module - The present invention relates to a medical injection system comprising a medical injection device ( | 09-11-2014 |
20150065963 | Medical Injection Device - The present invention relates to an injection device ( | 03-05-2015 |
Erik Bundsbaek Mouridsen, Skjern DK
Patent application number | Description | Published |
---|---|---|
20090036057 | METHOD OF AND SYSTEM FOR TRANSMITTING SIGNALS USING FREQUENCY HOPPING - Method of and system for transmitting signals, e.g. control signals, request signals, interrogation signals etc. in a control system comprising at least two units, wherein at least one of said units is designed to operate as a master unit and wherein at least one of said units is designed to operate as a slave unit, | 02-05-2009 |
Henning Mouridsen, Holte DK
Patent application number | Description | Published |
---|---|---|
20110027777 | METHOD FOR PERFORMING PROGNOSIS FOR HIGH-RISK BREAST CANCER PATIENTS USING TOP2A GENE ABERRATIONS - A first exemplary method for performing a prognosis for a breast cancer patient, comprises the steps of determining the status of an aberration of the TOP2A gene in a tissue sample taken from the patient; and estimating the probability of either recurrence-free survival or of overall survival of the patient at a later time based upon a pre determined Hazard Ratio corresponding to the determined status. A second such exemplary method comprises the steps of determining the status of an aberration of the TOP2A gene in a tissue sample taken from the patient; and estimating the probability of either recurrence-free survival or of overall survival of the patient at a later time based upon a pre-determined Kaplan-Meier plot corresponding to the determined status. | 02-03-2011 |
Henning T. Mouridsen, Holte DK
Patent application number | Description | Published |
---|---|---|
20090042187 | COMPOSITIONS AND METHODS FOR PREDICTING OUTCOME OF TREATMENT - This invention is directed to compositions and their uses for detection of markers. Such markers may be useful in the understanding of the underlying molecular event leading to a condition or a disease in a subject. These markers may also be useful for characterization of neoplastic cells and cancer cells and their response to certain therapeutical regimes. Therefore the invention as disclosed may contribute to the improvement of the stratification of patients for the best possible treatment. | 02-12-2009 |
Kim Mouridsen, Hjortshoj DK
Patent application number | Description | Published |
---|---|---|
20130266197 | METHOD FOR DELINEATION OF TISSUE LESIONS - The present invention relates to a method for estimating a measure of a penumbra size of a penumbra in biological tissue wherein first and second images obtained respectively by perfusion weighted imaging (PWI) and diffusion weighted imaging (DWI) are analyzed, and wherein the analysis of the first image includes application of a level set method, and the analysis of the second image includes application of a grayscale morphological operation. In a further embodiment of the invention, a connected component labeling algorithm maybe applied on any one of the first and second image. The invention further relates to a system, a computer program product and use of a corresponding method. | 10-10-2013 |
20140018649 | SYSTEM FOR ASSESSING TISSUE SUBSTANCE EXTRACTION - The present invention relates to a system for measuring a micro-vascular flow distribution of a tissue portion of a mammal comprising means ( | 01-16-2014 |
Kim Mouridsen, Hjortshøj DK
Patent application number | Description | Published |
---|---|---|
20140039320 | ULTRASONIC SYSTEM FOR ASSESSING TISSUE SUBSTANCE EXTRACTION - The present invention relates to an ultrasonic system for measuring a micro-vascular flow distribution of a tissue portion of a mammal comprising an ultrasonic transducer ( | 02-06-2014 |